The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Uranova N.A.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Vikhreva O.V.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Rakhmanova V.I.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Orlovskaia D.D.

Nauchnyĭ tsentr psikhicheskogo zdorov'ia RAMN, Moskva

Ultrastructural pathology of oligodendrocytes in the white matter in continuous paranoid schizophrenia: a role for microglia

Authors:

Uranova N.A., Vikhreva O.V., Rakhmanova V.I., Orlovskaia D.D.

More about the authors

Read: 1219 times


To cite this article:

Uranova NA, Vikhreva OV, Rakhmanova VI, Orlovskaia DD. Ultrastructural pathology of oligodendrocytes in the white matter in continuous paranoid schizophrenia: a role for microglia. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(9):76‑81. (In Russ.)
https://doi.org/10.17116/jnevro20171179176-81

Recommended articles:
Ultrastructural and morphometric features of follicular thyroid adenomas. Russian Journal of Archive of Pathology. 2026;(1):18-25

References:

  1. Flynn SW, Lang DJ, Mackay AL, Goghari V, Vavasour IM, Whittall KP, Smith GN, Arango V, Mann JJ, Dwork AJ, Falkai P, Honer WG. Abnormalities of myelination in schizophrenia detected in vivo with MRI, and post-mortem with analysis of oligodendrocyte proteins. Mol Psychiatry. 2003;8(9):811-820.
  2. Takahashi N, Sakurai T, Davis KL, Buxbaum JD. Linking oligodendrocyte and myelin dysfuntion to neurocircuitry abnormalities in schizophrenia. Prog Neurobiol. 2011;93(1):13-24. https://doi.org/10.1016/j.pneurobio.2010.09.004
  3. Nave KA. Myelination and support of axonal integrity by glia. Nature. 2010;468:244-252. https://doi.org/10.1038/nature09614
  4. Uranova NA, Kolomeets NS, Vikhreva OV, Zimina IS, Rakhmanova VI, Orlovskaya DD. Ultrastructural changes of myelinated fibers in the brain in continuous and attack-like paranoid schizophrenia. Zh nevrol psikhiatr im. S.S. Korsakova. 2017;117(2):104-109. (In Russ.). https://doi.org/10.17116/jnevro201711721104-109
  5. Uranova NA, Vikhreva OV, Rachmanova VI, Orlovskaya DD. Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment. 2011;325789. https://doi.org/10.1155/2011/325789
  6. Vostrikov VM, Uranova NA, Rakhmanova VI, Orlovskaia DD. Lowered oligodendroglial cell density in the prefrontal cortex in schizophrenia. Zh nevrol psikhiatr im. S.S.Korsakova. 2004;104(1):47-51. (In Russ.).
  7. Vikhreva OV, Rakhmanova VI, Orlovskaya DD, Uranova NA. Ultrastructural alterations of oligodendrocytes in prefrontal white matter in schizophrenia: A post-mortem morphometric study. Schizophr Res. 2016;177(1-3):28-36. https://doi.org/10.1016/j.schres.2016.04.023
  8. Chew LJ, Fusar-Poli P, Schmitz T. Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia. Dev Neurosci. 2013;35(2-3):102-129. https://doi.org/10.1159/000346157
  9. Najjar S, Pearlman DM. Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res. 2015;161(1):102-112. https://doi.org/10.1016/j.schres.2014.04.041
  10. Chiappelli J, Hong LE, Wijtenburg SA, Du X, Gaston F, Kochunov P, Rowland LM. Alterations in frontal white matter neurochemistry and microstructure in schizophrenia: implications for neuroinflammation. Transl Psychiatry. 2015;5:548. https://doi.org/10.1038/tp.2015.43
  11. Glezer II, Sukhorukova LI. Structural features of neuroglia in schizophrenia of the periodic and uninterruped types (histological and electron microscopic study). Zh nevropatol psikhiatr im. S.S. Korsakova. 1966;66(10):1529-1537. (In Russ.).
  12. Sukhorukova LI. Changes in neuroglia in continuous schizophrenia. Zh nevropatol psikhiatr im. S.S. Korsakova. 1966;66(9):1408-1416. (In Russ.).
  13. Davis JM. Dose-equivalence of antipsychotic drugs. J Psychiatry Res. 1974;11:65-69. (In Russ.).
  14. Rey M-J, Schulz P, Costa C, Dick P, Tissot R. Guidelines for the dosage of neuroleptics. I: chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol. 1989;4(2):95-104.
  15. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64(6):663-667.
  16. Gundersen HJ, Bagger P, Bendtsen TF, Evans SM, Korbo L, Marcussen N, Møller A, Nielsen K, Nyengaard JR, Pakkenberg B, et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 1988;96(10):857-881.
  17. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry. 2004;9(7):684-697, 643.
  18. Bitanihirwe BKY, Tsung-Ung W, WooT-U W. Oxidative stress in schizophrenia: An integrated approach. Neurosci Biobehav Rev. 2011;35(3):878-893. https://doi.org/10.1016/j.neubiorev.2010.10.008
  19. Barateiro A, Brites D, Fernandes A. Oligodendrocyte Development and myelination in neurodevelopment: Molecular mechanisms in health and disease. Curr Pharm Des. 2016;22(6):656-679.
  20. Funfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Möbius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 2012;485:517-521. https://doi.org/10.1038/nature11007
  21. Albayrak Y, Ünsal C, Beyazyüz M, Ünal A, Kuloğlu M. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study. Prog Neuropsychopharmacol Biol Psychiatry. 2013;45:144-149. https://doi.org/10.1016/j.pnpbp.2013.04.020
  22. Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT. Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol. 2011;14(1):123-130. https://doi.org/10.1017/S1461145710000805
  23. Chowdari KV, Bamne MN, Nimgaonkar VL. Genetic association studies of antioxidant pathway genes and schizophrenia. Antioxid Redox Signal. 2011;15(7):2037-2045. https://doi.org/10.1089/ars.2010.3508
  24. Brunk UT, Terman А. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med. 2002;33(5):611-619.
  25. Fillman SG, Cloonan N, Catts VS, Miller LC, Wong J, McCrossin T, Cairns M, Weickert CS. Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia. Mol Psychiatry. 2013;18(2):206-214. https://doi.org/10.1038/mp.2012.110
  26. Wierzba-Bobrowicz T, Lewandowska E, Lechowicz W, Stepień T, Pasennik E. Quantitative analysis of activated microglia ramified and damage of processes in the frontal and temporal lobes of chronic schizophrenics. Folia Neuropathol. 2005;43(2):81-89.
  27. Rao JS, Kim HW, Harry GJ, Rapoport SI, Reese EA. Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients. Schizophr Res. 2013;147(1):24-31. https://doi.org/10.1016/j.schres.2013.02.017
  28. Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC. Neuroinflammation in schizophrenia-related psychosis: a PET study. Journal of Nuclear Medicine. 2009;50(11):1801-1807. https://doi.org/10.2967/jnumed.109.066647
  29. Trépanier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP. Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry. 2016;21(8):1009-1026. https://doi.org/10.1038/mp.2016.90
  30. Hercher C, Chopra V, Beasley CL. Evidence for morphological alterations in prefrontal white matter glia in schizophrenia and bipolar disorder. J Psychiatry Neurosci. 2014;39(6):376-385.
  31. Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL. Mitochondrial dysfunction and psychiatric disorders. Neurochem Res. 2009;34(6):1021-1029. https://doi.org/10.1007/s11064-008-9865-8
  32. Ben-Shachar D, Karry R. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One. 2008;3(11):3676. https://doi.org/10.1371/journal.pone.0003676
  33. Martins-de-Souza D, Harris LW, Guest PC, Bahn S. The role of energy metabolism dysfunction and oxidative stress in schizophrenia revealed by proteomics. Antioxid Redox Signal. 2011;15(7):2067-2079. https://doi.org/10.1089/ars.2010.3459
  34. Merrill JE, Ignarro LJ, Sherman MP, Melinek J, Lane TE. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol. 1993;151:2132-2141.
  35. Paterson GJ, Ohashi Y, Reynolds GP, Pratt JA, Morris BJ. Selective increases in the cytokine, TNFalpha, in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects: influence of antipsychotic drugs. J Psychopharmacol. 2006;20(5):636-642.
  36. Fillman SG, Sinclair D, Fung SJ, Webster MJ, Weickert S. Markers of inflammation and stress distinguish subsets of individuals with schizophrenia and bipolar disorder. Transl Psychiatry. 2014;4:365. https://doi.org/10.1038/tp.2014.8
  37. Arion D, Unger T, Lewis DA, Levitt P, Mirnics K. Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry. 2007;62(7):711-721.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.